ACC 2026 | DKCRUSH VIII: IVUS or angiography to guide PCI in complex coronary bifurcations


Intracoronary imaging guidance has become an established recommended strategy in complex coronary lesions. In the specific setting of complex bifurcations, uncertainty remained regarding the incremental benefit over an angiography-guided approach alone. This question is particularly relevant in the DK crush technique, which involves multiple steps in which procedural optimization—especially the rewiring step—may be critical to the effectiveness of the technique.

Cobertura Científica SOLACI ACC 2026

The aim of the DKCRUSH VIII study was to investigate the effect of an IVUS-guided PCI strategy compared with an angiography-guided PCI in patients with true complex coronary bifurcation lesions.

A randomized study was conducted across 24 centers in China, enrolling 556 patients, with 278 assigned to IVUS-guided DK crush and 278 to angiography-guided DK crush. Patients older than 18 years with truly complex bifurcations were included, defined—among other criteria—by a side branch lesion ≥10 mm, side branch ostial stenosis of 70% to 90%, plus two minor criteria, and MV-QFR ≤0.8.

The primary endpoint (PFP) was target vessel failure (TVF) at 12 months, defined as a composite of cardiac death, target vessel myocardial infarction, or clinically driven target vessel revascularization.

The mean age was 67 years, and 77.3% of patients were male. Most patients presented with unstable angina, and approximately 18% with STEMI. From an anatomical and procedural standpoint, nearly half involved distal left main bifurcations; radial access was predominant, and the DK crush technique was used in 96.8% of both groups.

Read also: ACC 2026 | OPTIMAL: IVUS Guidance in PCI of the Unprotected Left Main Coronary Artery.

At 1-year follow-up, the primary endpoint occurred in 6.1% of the IVUS group and 14.7% of the angiography-guided group (HR 0.40; 95% CI 0.23–0.71; p=0.0016). Reductions were also observed in several clinical components: target vessel MI in 4.3% vs 9.4% (HR 0.46; p=0.02), spontaneous MI in 1.8% vs 6.1% (HR 0.29; p=0.01), and TVR in 2.9% vs 7.6% (HR 0.37; p=0.02). There were no significant differences in all-cause mortality (1.4% vs 1.1%; p=0.70), cardiac death (0.7% vs 1.1%; p=0.66), or definite/probable stent thrombosis (0.4% vs 1.1%; p=0.38).

Systematic IVUS evaluation identified relevant procedural findings, including incomplete crushing in 28.2%, distal rewiring after the first rewiring in 41.5%, and suboptimal diameter after final POT in 61.0% of evaluated patients.

Read also: ACC 2026 | Extended follow-up of the TRI-FR study: Edge-to-edge percutaneous repair in isolated severe tricuspid regurgitation.

An additional exploratory analysis showed that when IVUS-defined optimization criteria were achieved, the TVF rate was 2.6%, compared with 15.9% in suboptimal PCI and 14.7% in the angiography-guided arm.

Conclusions: IVUS significantly reduces target vessel failure in complex coronary bifurcations treated with DK crush

In this randomized study, IVUS-guided DK crush was associated with a lower rate of TVF at one year compared with angiography-guided PCI in complex coronary bifurcations. This benefit was primarily driven by achieving IVUS-defined optimization targets rather than by the mere use of IVUS.

Presented by Shao-Liang Chen at the Late-Breaking Clinical Trials, ACC.26, March 28–30, New Orleans, USA.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

Dr. Omar Tupayachi
Dr. Omar Tupayachi
Member of the Editorial Board of solaci.org

More articles by this author

Ticagrelor vs Clopidogrel in ACS Patients Receiving DOAC After PCI: More Bleeding Without Ischemic Benefit?

In patients with acute coronary syndrome (ACS) who require direct oral anticoagulation (DOAC) and undergo percutaneous coronary intervention (PCI), current guidelines recommend a dual...

EuroPCR 2026 | 10-Year Left Main PCI: When Survival Is Similar, Should the Less Invasive Strategy Prevail?

The primary goal of revascularization in left main coronary artery disease (LMCA) is to improve survival. However, debate continues regarding whether, in anatomically suitable...

EuroPCR 2026 | TAVI and Coronary Artery Disease: FFR-Guided PCI Showed Better Outcomes Than an Angiography-Guided Strategy

In patients undergoing TAVI, the concomitant presence of coronary artery disease continues to generate debate: whether coronary lesions should be treated before, during, or...

EuroPCR 2026 | Evolocumab Reduces Cardiovascular Events in Patients With Prior PCI Without Previous Myocardial Infarction: VESALIUS-CV Results

This presentation, delivered by Dr. Brian A. Bergmark and colleagues at EuroPCR 2026, detailed the results of the VESALIUS-CV trial, focusing specifically on the...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img
Jornadas Guatemala 2026

Recent Articles

Ticagrelor vs Clopidogrel in ACS Patients Receiving DOAC After PCI: More Bleeding Without Ischemic Benefit?

In patients with acute coronary syndrome (ACS) who require direct oral anticoagulation (DOAC) and undergo percutaneous coronary intervention (PCI), current guidelines recommend a dual...

T-TEER: Beyond Traditional Pulmonary Hypertension Thresholds

Significant tricuspid regurgitation (TR) is associated with progressive functional deterioration, heart failure (HF) hospitalizations, and increased mortality. In recent years, transcatheter tricuspid edge-to-edge repair...

Is left atrial appendage closure safe in patients with reduced ejection fraction?

Patients with heart failure with reduced ejection fraction (HFrEF) were excluded from the major randomized trials evaluating percutaneous left atrial appendage closure (LAAC), and...